Advanced Filters
noise

amyloidosis Clinical Trials

A listing of amyloidosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 157 clinical trials
R René Nkoulou, Dr.

Effect of Radiotherapy on ATTR Cardiac Amyloidosis : a Proof of Concept Study

Cardiac amyloidosis is responsible for significant morbidity associated with heart failure, and carries a poor prognosis. Currently there are very limited treatment options for this condition. Radiotherapy has been used successfully to treat amyloidosis elsewhere in the body, however has not been tried in cardiac amyloidosis. Therefore this study aims …

65 - 100 years of age Both Phase N/A
S Sarah Cuddy, MD

Exercise Training in Transthyretin Cardiac Amyloidosis

Transthyretin cardiac amyloidosis causes debilitating heart failure in older adults. The proposed research will develop a personalized exercise training program to improve functional capacity in patients on optimal treatment for transthyretin cardiac amyloidosis. This is a vital next step to improve functional capacity and quality of life of people suffering …

60 - 90 years of age Both Phase N/A

A Study to Assess Safety of ABBV-916 and How Intravenous ABBV-916 Moves Through Body and Affects Brain Amyloid Plaque Clearance in Adult Participants (Aged 50-90 Years) With Early Alzheimer's Disease

Alzheimer's disease (AD) is a progressive, irreversible neurological disorder and is the most common cause of dementia in the elderly population. Clinical symptoms of the disease may begin with occasional forgetfulness such as misplacement of items, forgetting important dates or events, and may progress to noticeable memory loss, increased confusion …

50 - 90 years of age Both Phase 2
T Timothy J. Poterucha, MD

Cardiac Amyloidosis Discovery Trial

This is a single center, diagnostic clinical trial in which the investigators aim to prospectively validate a deep learning model that identifies patients with features suggestive of cardiac amyloidosis, including transthyretin cardiac amyloidosis (ATTR-CA). Cardiac Amyloidosis is an age-related infiltrative cardiomyopathy that causes heart failure and death that is frequently …

50 - 100 years of age Both Phase N/A
A Adrienne Hilliard

Study of AV-1959, an Amyloid Beta Vaccine

Phase 1 clinical trial of AV-1959 amyloid-β vaccine for Alzheimer's disease (AD).

60 - 85 years of age Both Phase 1
C Candice Delrio, RN

Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders

The main purpose of this study is to examine the outcome of a combined bone marrow and kidney transplant from a partially matched related (haploidentical or "haplo") donor. This is a pilot study, you are being asked to participate because you have a blood disorder and kidney disease. The aim …

18 - 70 years of age Both Phase N/A
X Xianghua Huang, MD

Daratumumab for Patients With Light Chain Amyloidosis

This is a prospective, single-center study exploratory clinical trial, aim to exploring the efficacy and safety of daratumumab in patients with AL amyloidosis, patients were divided into three groups: one group received long-term treatment with daratumumab based regimen, and the other group received autologous stem cell transplantation after two standard …

18 - 75 years of age Both Phase N/A
D Dana Amaro

CAPACITY (Cardiac Amyloidosis and Physical ACtivITY) Study

Exercise training in patients with heart failure and preserved ejection fraction (HFpEF) has been associated with an improvement in cardiorespiratory fitness and quality of life.

18 - 100 years of age Both Phase N/A
S Sharmila Dorbala, MBBS, MPH

Molecular Imaging of Myocardial Fibrosis in Cardiac Amyloidosis

The primary aim of our pilot study is to determine whether fibrosis in the heart can be measured with [68Ga]CBP8, a positron emission tomography (PET) probe, using PET/magnetic resonance imaging (MRI) imaging, in 30 individuals with documented cardiac amyloidosis. The investigators will also enroll 15 individuals with recent myocardial infarction …

18 - 100 years of age Both Phase 3
A Astrid MONFORT BRAFINE, MD

Heart Failure: Don't Forget the Role of Amyloidosis

Heart failure is defined as the inability of the heart to provide sufficient output to meet the needs of the body. It can occur in the course of a myocardial infarction, angina pectoris, hypertension, etc. Its frequency increases with age. It is a major public health problem. Heart failure first …

50 - 100 years of age Both Phase N/A

Rewrite in simple language using AI